Active Ingredient Tafamidis Meglumine

Active Ingredient Details

What is the usage for Tafamidis Meglumine?

This medication is used to treat a certain type of heart failure (transthyretin-mediated amyloidosis). It is used to help prevent the heart failure from getting worse and needing treatment in a hospital. Tafamidis works by slowing the buildup of a certain protein (amyloid fibrils) that causes heart problems.

How many products in the NDC database contain Tafamidis Meglumine?

The NDC database has 10 products with the active ingredient Tafamidis Meglumine. The following table lists all the products that have this active ingredient.

NDC Products with Tafamidis Meglumine

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-1975Proprietary Name: Vyndaqel Tafamidis MeglumineCapsule, Liquid FilledOralPfizer Laboratories Div Pfizer IncACTIVE
11014-0207Proprietary Name: Tafamidis MeglumineCapsuleCatalent Pharma Solutions, LlcACTIVE
11712-829Proprietary Name: Tafamidis MegluminePowderDelmar Chemicals IncACTIVE
14501-0101Proprietary Name: Tafamidis MegluminePowderMsn Laboratories Private LimitedACTIVE
58032-2037Proprietary Name: Tafamidis MegluminePowderNeuland Laboratories LimitedACTIVE
58159-078Proprietary Name: Tafamidis MegluminePowderNuray Chemicals Private LimitedACTIVE
59651-709Proprietary Name: Tafamidis MegluminePowderAurobindo Pharma LimitedACTIVE
66039-959Proprietary Name: Tafamidis MegluminePowderGlenmark Life Sciences LimitedACTIVE
69037-0065Proprietary Name: Tafamidis MegluminePowderHonour Lab LimitedACTIVE
73435-024Proprietary Name: Tafamidis MegluminePowderBiophore India Pharmaceutical Pvt LtdACTIVE
<